FULC
Fulcrum Therapeutics Inc
NASDAQ · Pharmaceuticals
$9.74
+0.19 (+1.99%)
Open$9.71
Previous Close$9.55
Day High$10.00
Day Low$9.62
52W High$15.74
52W Low$2.32
Volume—
Avg Volume481.8K
Market Cap642.55M
P/E Ratio—
EPS$-0.86
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
+485.0% upside
Current
$9.74
$9.74
Target
$56.98
$56.98
$37.54
$56.98 avg
$60.88
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 85.15M | 52.88M | 380.48M |
| Net Income | -10,350,739 | -5,785,049 | 50.86M |
| Profit Margin | -12.2% | -11.6% | 13.4% |
| EBITDA | -8,655,302 | -5,106,214 | 71.18M |
| Free Cash Flow | — | — | 46.38M |
| Rev Growth | +61.0% | +61.0% | -8.7% |
| Debt/Equity | — | — | 0.68 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |